Kenneth Anderson Selected Research

melflufen

5/2020	Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1-2 study.
9/2017	Melflufen - a peptidase-potentiated alkylating agent in clinical trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenneth Anderson Research Topics

Disease

53	Multiple Myeloma 12/2023 - 01/2002
16	Neoplasms (Cancer) 04/2024 - 01/2002
3	Compression Fractures (Compression Fracture) 11/2018 - 06/2007
3	Bone Diseases (Bone Disease) 06/2007 - 11/2006
2	Genomic Instability 05/2024 - 04/2015
2	Residual Neoplasm 02/2024 - 07/2013
2	Neutropenia 01/2023 - 05/2020
2	Infections 01/2023 - 09/2014
2	Disease Progression 12/2020 - 09/2014
2	Metabolic Bone Diseases (Osteopenia) 10/2018 - 06/2007
2	Necrosis 01/2017 - 01/2002
2	Asthma (Bronchial Asthma) 11/2013 - 07/2006
2	Chromosome Aberrations (Chromosome Abnormalities) 03/2010 - 11/2006
2	Renal Insufficiency (Renal Failure) 01/2007 - 11/2006
2	Inflammation (Inflammations) 07/2006 - 01/2004
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 07/2006 - 06/2006
2	Leukemia 01/2004 - 01/2004
2	Hematologic Neoplasms (Hematological Malignancy) 01/2004 - 01/2004
1	Smoldering Multiple Myeloma 04/2024
1	Cytokine Release Syndrome 01/2023
1	cell-associated neurotoxicity 01/2023
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2023
1	Herpes Simplex 01/2023
1	Cytopenia 01/2023
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2023
1	Thrombocytopenia (Thrombopenia) 05/2020
1	Pneumonia (Pneumonitis) 01/2019
1	Heart Arrest (Cardiac Arrest) 01/2019
1	Hepatic Encephalopathy 01/2019
1	Type 2 Diabetes Mellitus (MODY) 11/2018
1	Hypertension (High Blood Pressure) 11/2018
1	Hypothyroidism 11/2018
1	Anemia 11/2018
1	Plasma Cell Leukemia 12/2015
1	Prediabetic State (Prediabetes) 06/2014
1	Insulin Resistance 06/2014

Drug/Important Bio-Agent (IBA)

14	Lenalidomide (CC 5013)FDA Link 04/2024 - 06/2007
13	Dexamethasone (Maxidex)FDA LinkGeneric 04/2024 - 01/2004
13	Bortezomib (Velcade)FDA Link 01/2023 - 01/2004
6	Thalidomide (Thalomid)FDA Link 12/2020 - 01/2002
5	Melphalan (Alkeran)FDA LinkGeneric 12/2020 - 07/2010
4	Proteins (Proteins, Gene)FDA Link 11/2018 - 01/2004
3	pomalidomideIBA 01/2023 - 01/2019
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2023 - 01/2011
2	VaccinesIBA 12/2023 - 07/2013
2	Immunomodulating AgentsIBA 01/2023 - 10/2013
2	Proteasome InhibitorsIBA 01/2023 - 10/2013
2	Monoclonal AntibodiesIBA 01/2023 - 04/2015
2	melflufenIBA 05/2020 - 09/2017
2	Zoledronic Acid (Zometa)FDA Link 10/2018 - 06/2007
2	Pamidronate (Aredia)FDA LinkGeneric 10/2018 - 06/2007
2	CateninsIBA 01/2017 - 03/2014
2	Oncogene Proteins (Oncogene Protein)IBA 01/2016 - 07/2008
2	Glucose (Dextrose)FDA LinkGeneric 06/2014 - 02/2014
2	Phosphotransferases (Kinase)IBA 06/2014 - 11/2003
2	Prednisone (Sone)FDA LinkGeneric 04/2011 - 07/2010
2	Diphosphonates (Bisphosphonates)IBA 03/2009 - 06/2007
2	AntigensIBA 07/2006 - 06/2006
1	Biomarkers (Surrogate Marker)IBA 05/2024
1	ixazomibIBA 04/2024
1	RNA (Ribonucleic Acid)IBA 04/2024
1	trans-crotonin (CTN)IBA 12/2023
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 11/2023
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2023
1	Bispecific AntibodiesIBA 01/2023
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2023
1	ChromatinIBA 10/2022
1	isatuximabIBA 11/2019
1	Metformin (Glucophage)FDA LinkGeneric 11/2018
1	DiureticsIBA 11/2018
1	Thyroxine (Levothyroxine)FDA LinkGeneric 11/2018
1	Polycomb Repressive Complex 1IBA 09/2017
1	AminopeptidasesIBA 09/2017
1	CD13 Antigens (Alanine Aminopeptidase)IBA 09/2017
1	elotuzumabIBA 09/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 09/2017
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	(arginine)9- cysteinyl- glutaminyl- cysteinyl- arginyl- arginyl- lysyl- asparagineIBA 01/2017
1	Interferon Regulatory FactorsIBA 01/2017
1	Cell-Penetrating PeptidesIBA 01/2017
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2016
1	lactate dehydrogenase 2IBA 12/2015
1	Immunotoxins (Immunotoxin)IBA 04/2015
1	Triglycerides (Triacylglycerol)IBA 06/2014
1	salicylsalicylic acid (salsalate)IBA 06/2014
1	SalicylatesIBA 06/2014
1	Nonesterified Fatty Acids (NEFA)IBA 06/2014
1	CytokinesIBA 06/2014
1	MicroRNAs (MicroRNA)IBA 03/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2014

Therapy/Procedure

22	Therapeutics 01/2023 - 04/2003
5	Stem Cell Transplantation 09/2014 - 01/2004
3	Cell Transplantation 12/2023 - 12/2015
3	Transplantation 12/2015 - 11/2013
2	Drug Therapy (Chemotherapy) 08/2016 - 07/2004
1	Aftercare (After-Treatment) 02/2024
1	Immunomodulation 01/2023
1	Precision Medicine 12/2018
1	Intravenous Administration 10/2018
1	Duration of Therapy 03/2014